A Case of Radiation Recall Dermatitis which Developed in a Patient with Kaposi Sarcoma.
- Author:
Sang Eun LEE
1
;
Wook LEW
Author Information
1. Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea. wlewderm@yumc.yonsei.ac.kr
- Publication Type:Case Report
- Keywords:
Doxorubicin;
Kaposi sarcoma;
Radiation recall dermatitis
- MeSH:
Adult;
Doxorubicin;
Drug Therapy;
Erythema;
Female;
Humans;
Ifosfamide;
Inflammation;
Pruritus;
Radiation, Ionizing;
Radiodermatitis*;
Radiotherapy;
Recurrence;
Sarcoma, Kaposi*;
Skin
- From:Korean Journal of Dermatology
2006;44(3):338-340
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Radiation recall dermatitis is a rare skin reaction, occurring subsequent to drug administration, and has all the clinical signs of inflammation, which develop in a previously irradiated area, days to years after exposure to ionizing radiation. A 41-year-old woman was diagnosed with Kaposi sarcoma. The patient was treated by radiotherapy, followed by a 1st chemotherapy session with doxorubicin and ifosfamide, 20 days after the radiotherapy. However, the patient developed erythema of the skin, accompanied by pruritus and pain in the previously irradiated area, 3 to 4 days after the chemotherapy. The erythema resolved almost completely after systemic and topical steroid therapy. The patient received a 2nd chemotherapy session with the same regimen, but there was no recurrence of radiation recall dermatitis. We report a case of an uncommon skin reaction after chemotherapy in a patient with kaposi sarcoma, which was identified as radiation recall dermatitis.
